LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 110 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $3,123,000 | -76.3% | 66,455 | -68.6% | 0.38% | -74.0% |
| Q2 2014 | $13,185,000 | -33.8% | 211,665 | -28.5% | 1.48% | -29.7% |
| Q1 2014 | $19,918,000 | -8.7% | 296,095 | -28.6% | 2.10% | +16.1% |
| Q4 2013 | $21,823,000 | +7.6% | 414,888 | -6.6% | 1.81% | +4.6% |
| Q3 2013 | $20,273,000 | -35.5% | 444,200 | -47.1% | 1.73% | -31.8% |
| Q2 2013 | $31,422,000 | – | 840,171 | – | 2.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |